Abstract | BACKGROUND: The anti-natriuretic properties of growth hormone (GH) are well established. Growth hormone deficiency (GHD) results in salt and water depletion and studies confirm that replacement leads to sodium and vasopressin-mediated water retention in patients with intact posterior pituitary function. METHODS: We report the case of a 20-year-old male patient with septo-optic dysplasia, fixed cranial diabetes insipidus (DI) and an abnormal thirst threshold. With careful parental support, his sodium levels remained stable for many years on a fixed dose of DDAVP and a supervised fluid intake of 2.5 l/day. Several years after the original diagnosis, he was found to be ACTH deficient and following commencement of hydrocortisone replacement therapy became hypernatraemic. A new sodium homoeostasis was established with a higher dose of DDAVP. Subsequently, he developed symptoms typical of GHD and, after biochemical confirmation, GH replacement was commenced. RESULTS: There was an immediate clinical improvement (increased alertness, improved concentration) but severe hypernatraemia developed (peak 169 mmol/l) necessitating revision of his desmopressin and fluid intake regimen. CONCLUSION: Most GHD patients have intact posterior pituitary function. This case report highlights the powerful anti-natriuretic properties of GH. Endocrine physicians should be alert to this in patients with fixed DI and an abnormal thirst threshold.
|
Authors | Shivani Misra, Linda Brown Johnston, William Martyn Drake |
Journal | Pituitary
(Pituitary)
Vol. 13
Issue 2
Pg. 186-8
(Jun 2010)
ISSN: 1573-7403 [Electronic] United States |
PMID | 18814036
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
|
Topics |
- Growth Hormone
(adverse effects, therapeutic use)
- Hormone Replacement Therapy
(adverse effects)
- Humans
- Hypernatremia
(chemically induced)
- Male
- Septo-Optic Dysplasia
(drug therapy)
- Young Adult
|